Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025)

Eton Pharmaceuticals' FCF Margin history spans 7 years, with the latest figure at 54.51% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 4784.0% to 54.51% in Q4 2025 year-over-year; TTM through Dec 2025 was 15.81%, a 1339.0% increase, with the full-year FY2025 number at 12.75%, up 1033.0% from a year prior.
  • FCF Margin hit 54.51% in Q4 2025 for Eton Pharmaceuticals, down from 52.28% in the prior quarter.
  • Over the last five years, FCF Margin for ETON hit a ceiling of 117.02% in Q1 2025 and a floor of 380.9% in Q3 2021.
  • Historically, FCF Margin has averaged 7.79% across 5 years, with a median of 13.13% in 2024.
  • The widest YoY moves for FCF Margin: up 1425297bps in 2021, down -24095071bps in 2021.
  • Tracing ETON's FCF Margin over 5 years: stood at 84.05% in 2021, then skyrocketed by 140bps to 33.28% in 2022, then tumbled by -96bps to 1.3% in 2023, then plummeted by -614bps to 6.67% in 2024, then crashed by -717bps to 54.51% in 2025.
  • Business Quant data shows FCF Margin for ETON at 54.51% in Q4 2025, 52.28% in Q3 2025, and 42.05% in Q2 2025.